Vividion Therapeutics starts Phase I clinical trial in advanced solid tumors with KEAP1 activator
Berlin, Germany, San Diego, CA, USA, September 18, 2023 – Vividion Therapeutics, Inc. (Vividion), announced today that it has initiated ...
Read moreDetails